during consolidation therapy, is a marker of good prognosis, and flow cytometry is the most commonly used method for MRD detection in AML patients.
Keyphrases
- flow cytometry
- acute myeloid leukemia
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- loop mediated isothermal amplification
- prognostic factors
- peritoneal dialysis
- allogeneic hematopoietic stem cell transplantation
- stem cells
- bone marrow
- mesenchymal stem cells
- acute lymphoblastic leukemia
- chemotherapy induced